Atlas Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Sell |
35,374
-662
| -2% | -$11.1K | 0.07% | 221 |
|
|
2025
Q1 | $554K | Sell |
36,036
-5,004
| -12% | -$76.9K | 0.07% | 238 |
|
|
2024
Q4 | $905K | Sell |
41,040
-2,079
| -5% | -$45.8K | 0.11% | 153 |
|
|
2024
Q3 | $777K | Sell |
43,119
-772
| -2% | -$13.9K | 0.12% | 154 |
|
|
2024
Q2 | $713K | Buy |
43,891
+149
| +0.3% | +$2.42K | 0.09% | 176 |
|
|
2024
Q1 | $617K | Buy |
43,742
+42,502
| +3,428% | +$600K | 0.1% | 188 |
|
|
2023
Q4 | $12.9K | Hold |
1,240
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $12.6K | Hold |
1,240
| – | – | ﹤0.01% | 683 |
|
|
2023
Q2 | $9.34K | Sell |
1,240
-20,687
| -94% | -$156K | ﹤0.01% | 743 |
|
|
2023
Q1 | $194K | Hold |
21,927
| – | – | 0.03% | 360 |
|
|
2022
Q4 | $200K | Hold |
21,927
| – | – | 0.03% | 339 |
|
|
2022
Q3 | $177K | Buy |
21,927
+9,250
| +73% | +$74.6K | 0.03% | 360 |
|
|
2022
Q2 | $95.3K | Hold |
12,677
| – | – | 0.02% | 470 |
|
|
2022
Q1 | $119K | Buy |
12,677
+1,987
| +19% | +$18.7K | 0.02% | 446 |
|
|
2021
Q4 | $85.6K | Buy |
10,690
+2,669
| +33% | +$21.4K | 0.01% | 474 |
|
|
2021
Q3 | $78.1K | Hold |
8,021
| – | – | 0.01% | 469 |
|
|
2021
Q2 | $79.4K | Hold |
8,021
| – | – | 0.01% | 477 |
|
|
2021
Q1 | $92.6K | Sell |
8,021
-4,455
| -36% | -$51.4K | 0.02% | 425 |
|
|
2020
Q4 | $120K | Hold |
12,476
| – | – | 0.03% | 371 |
|
|
2020
Q3 | $112K | Hold |
12,476
| – | – | 0.03% | 304 |
|
|
2020
Q2 | $154K | Sell |
12,476
-625
| -5% | -$7.71K | 0.04% | 348 |
|
|
2020
Q1 | $118K | Buy |
13,101
+13,029
| +18,096% | +$117K | 0.04% | 346 |
|
|
2019
Q4 | $705 | Hold |
72
| – | – | ﹤0.01% | 624 |
|
|
2019
Q3 | $495 | Sell |
72
-7,020
| -99% | -$48.3K | ﹤0.01% | 630 |
|
|
2019
Q2 | $65.5K | Sell |
7,092
-25,551
| -78% | -$236K | 0.02% | 446 |
|
|
2019
Q1 | $512K | Sell |
32,643
-560
| -2% | -$8.78K | 0.18% | 148 |
|
|
2018
Q4 | $512K | Buy |
33,203
+7,139
| +27% | +$110K | 0.21% | 133 |
|
|
2018
Q3 | $563K | Sell |
26,064
-9,513
| -27% | -$206K | 0.19% | 145 |
|
|
2018
Q2 | $823K | Sell |
35,577
-2,771
| -7% | -$64.1K | 0.29% | 99 |
|
|
2018
Q1 | $655K | Buy |
+38,348
| New | +$655K | 0.2% | 161 |
|